Home › Stocks › GDTC › Changes
Who bought & sold GDTC (Q3 2026)
Funds holding (Q3 2026)6
New positions4
Added1
Reduced0
Exited1
As of Q3 2026, 6 institutional funds reported holding GDTC (CYTOMED THERAPEUTICS LIMITED): 4 opened new positions, 1 added, 0 trimmed and 1 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.
New positions (4)
| Fund | Shares | Value | Weight |
|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP New | 31.40K | $26.47K | — |
| StoneX Group Inc. New | 26.96K | $24.45K | 0.0 |
| HRT FINANCIAL LP New | 25.64K | $21.00K | — |
| TWO SIGMA SECURITIES, LLC New | 12.98K | $10.94K | 0.0 |
Added to positions (1)
| Fund | Shares | Value | Weight | Change |
|---|---|---|---|---|
| UBS Group AG | 38.90K | $32.79K | — | +34.07K sh (+705.2%) |
Reduced positions (0)
No trims this quarter.
Exited positions (1)
Held in the prior quarter but not reported in the latest filing.
| Fund | Shares | Value | Weight |
|---|---|---|---|
| Axiom Investment Management LLC Exited | 7.03K | $7.24K | 0.0 |